Trial intelligence / Profile preview

STELLAR: Mesenchymal Stem Cells in Acute Severe Respiratory Failure

NCT02112500Phase 2Unknown

Sponsor
Asan Medical Center
Start
Feb 2014
Primary completion
Dec 2016
Countries
1
01

Overview

A Phase 2 trial of Lungcellgram in acute respiratory distress syndrome (ARDS), sponsored by Asan Medical Center. Status: unknown.

02

Drugs

Lungcellgram
03

Conditions

acute respiratory distress syndrome (ARDS)

Beyond the preview

Go deeper on NCT02112500.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02112500.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call